Biotechnology Industry Research Assistance Council(BIRAC)
VC Fund
New Delhi, India
Biotechnology Industry Research Assistance Council(BIRAC) is a VC fund in New Delhi focused on Health Care and Biotechnology. Biotechnology Industry Research Assistance Council (BIRAC) is a not-for-profit Section 8, Schedule B, Public Sector Enterprise, set up by Department of Biotechnology (DBT), Government of India as an Interface Agency to strengthen and empower the emerging Biotech enterprise to undertake strategic research and innovation, addressing nationallyrelevant product development needs.BIRAC is a industry-academia interface and implements its mandate through a wide range of impact initiatives, be it providing access to risk capital through targeted funding, technology transfer, IP management and handholding schemes that help bring innovation excellence to the biotech firms and make them globally competitive. In its Eight years of existence, BIRAC has initiated several schemes, networks and platforms that help to bridge the existing gaps in the industry-academia Innovation research and facilitate novel, high quality affordable products development through cutting edge technologies. BIRAC has initiated partnerships with several national and global partners to collaborate and deliver the salient features of its mandate.Vision“To Stimulate, foster and enhance the strategic research and innovation capabilities of the Indian biotech industry, particularly start-ups and SME’s, for creation of affordable products addressing the needs of the largest section of society”Key StrategiesFoster innovation and entrepreneurship Promote affordable innovation in key social sectors Empowerment of start-ups & small and medium enterprises Contribute through partners for capability enhancement and diffusion of innovation Enable commercialization of discovery Ensure global competitiveness of Indian enterprises BIRAC’s Core ValuesIntegrity Transparency Team work Excellence Commitment BIRAC’s aim is to play a transformative and catalytic role in building a US$ 100 billion Indian bioeconomy. We believe that the agents of change for building the Indian bioeconomy would be biotech start-ups & SMEs & hence our focus is on raising their capabilities
- Total investments:
- 54
- Last investment:
- Lead investor:
- 44%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Biotechnology Industry Research Assistance Council(BIRAC) invests in
Stages Biotechnology Industry Research Assistance Council(BIRAC) invests in
Countries Biotechnology Industry Research Assistance Council(BIRAC) invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $100k–$1.5M
- Grant
- $28k–$2.6M
- Pre-Seed
- $20k–$425k
Investment Focus
Industry
- Health Care 17 (31%)
- Biotechnology 15 (28%)
- Manufacturing 10 (19%)
- Medical Device 10 (19%)
- Medical 9 (17%)
Stage
- Grant 28 (52%)
- Seed 10 (19%)
- Pre-Seed 7 (13%)
- Non-equity Assistance 2 (4%)
- Series A 1 (2%)
Country
- India 44 (81%)
- United States 2 (4%)
- Singapore 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Douglas Rosenthal
Independent Researcher
|
Independent Researcher | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Fermbox Bio
|
Fermbox Bio offers sustainable, Synbio food products that match animal products in taste and nutrition while reducing environmental impact. | $2.6M / Grant / Jul 14, 2026 | |
Sea6 Energy
|
Sea6 Energy is a platform that utilizes the unlimited potential of the oceans in a sustainable and ethical way. It visualizes a future where the abundant oceans will be the biomass farms of the future, to provide solutions in energy, agriculture, and food.Sea6 Energy has a team of professionals from diverse fields like industrial automation,plant pathology, ocean engineering, bioprocess engineering, marine biology, and aerospace engineering, with the goal of building a whole new economy based on marine biomass.It develops technologies to convert biomass into biofuel, plant growth stimulants, plant defence products, animal feed ingredients, and other bio-renewable products to replace chemicals and plastics, effectively creating a Bio-refinery out of marine biomass, churning out a whole variety of products leaving nothing to waste.Sea6 Energy was founded on 2010 and is headquartered in Bangalore, India. | $2.6M / Grant / Jul 14, 2026 | |
Revelations Biotech
|
Revelations Biotech is a manufacturer of prebiotic food ingredients, probiotics, and enzymes. | $2.6M / Grant / Jul 14, 2026 | |
Telluris Biotech
|
Telluris Biotech India Private limited is involved in developing solutions to important issues plaguing the agricultural and food processing industries. They are currently developing alternatives to combat the plant parasitic pathogen, root knot nematode Meloidogyne incognita. Their research has established proof of concept for four differentproducts and are in the process of establishing field trials data for registration of their products. Root knot nematodes account for about 12.3% crop loss globally that is in the range of $167 billion and in India the losses are in the range of Rs. 21,068.73 million annually. The major crops affected in India are capsicum, tomato, chilli, okra, gherkins, muskmelon, watermelon, carnations, roses, gerbera and anthuriums. Nematode problems in these crops have reached an unprecedented level, wherein a loss of about 80% in crop yield has been reported in crops grown in protected conditions. It has also been reported that, nematode infestation makes the crop more sensitive to fungal infestations which leads to an increased crop loss. Considering these crop losses, Telluris Biotech India Private Limited is involved in developing integrated pest management strategies with products majorly targeting the root knot nematode Meloidogyne incognita. | $2.6M / Grant / Jul 14, 2026 | |
4baseCare
|
4baseCare provides precision oncology solutions with advanced genomics to help cancer patients. The company focuses on leveraging advanced genomic technologies to provide personalized cancer treatment solutions. By analyzing the genetic profile of cancer patients, 4baseCare aims to identify targeted therapies that are more effective and have fewerside effects compared to traditional treatments. Their services include genomic testing, data interpretation, and personalized treatment recommendations, which are designed to improve patient outcomes and support healthcare providers in delivering precision medicine. The company collaborates with various stakeholders, including hospitals, research institutions, and pharmaceutical companies, to advance cancer care and research. | $2.6M / Grant / Jul 14, 2026 | |
JioVio
|
Jiovio Healthcare is a pregnant women's care service. They provide products that include savemom, allohms, and allobaby. They provide services for adults and children. They are products for diagnostics kits that consist of connected devices. An online inquiry form is available on the company's website. | Seed / Dec 29, 2023 | |
OmniBRx Biotechnologies
|
The Omnibrx Biotechnologies brought is an universal solution for the most efficient adherent cell culture processing with ultimate simplicity and scalability. The compact system, designed for quick implementation and ease-of-use, represents a new generation of rigid wall single-use bioreactors. Central to the CellBRx bioreactors technology is theuse of a compact rotating dynamic-bed design, filled with custom disc shaped macro-carriers. This matrix discs are made of medical grade non-woven polyester microfibers (USP Class VI, ISO 10993 certifications) and available from 0.25L to 1000L working volume size. | $3.6M / Series A / Mar 13, 2023 | |
Hester Biosciences
|
Hester Biosciences Limited is an India-based company engaged in manufacturing of poultry vaccines and large animal vaccines, and trading of poultry health products and large animal health products. Its segments include Poultry Division and Large Animal Division. It provides over 40 products across poultry vaccines (live and inactivated), largeanimal vaccines (live and inactivated), health products and diagnostics. Its product range includes vaccines, drugs, feed supplements and disinfectants. It manufactures over two live vaccines for large animals, including Peste des Petits Ruminants (PPR) Live vaccines and Goat Pox Vaccine. Its offerings include Avian, including Live B1, Live LAS, Live R2B, Live M48, Live FP, Gumboro M1, Gumboro I and Gumboro I+; swine fever vaccines, and large animal, including PPR Vaccine-Sungri 96 strain and Brucella abortus (S19) calf Vaccine. It offers services, such as seromonitoring for poultry farms and mastitis prevention programs for cattle farms. | $7.9M / Grant / Apr 07, 2022 | |
Recyteq
|
Recyteq is building a digital ecosystem to collect human hair from saloons, process it as plant booster and sell it directly to urban gardeners and farmers through E-commerce | Non-equity Assistance / Mar 31, 2022 | |
Fibroheal
|
Fibroheal Woundcare uses the biomaterial property of silk and silk protein to provide wound care management for acute, chronic, surgical, and traumatic wounds. Its products include sheets, mesh, foams, powder, and particles. | $921.3K / Debt Financing / Mar 17, 2022 | |
| See all 54 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Biotechnology Industry Research Assistance Council(BIRAC) invest in?
Biotechnology Industry Research Assistance Council(BIRAC) invests primarily in Health Care, Biotechnology and Manufacturing startups, most often at Grant and Seed stage. Most of the 54 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Biotechnology Industry Research Assistance Council(BIRAC)'s check size?
Biotechnology Industry Research Assistance Council(BIRAC) typically joins rounds of $100k–$1.5M at Seed, $28k–$2.6M at Grant and $20k–$425k at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Biotechnology Industry Research Assistance Council(BIRAC) participates in.
How do I contact Biotechnology Industry Research Assistance Council(BIRAC)?
Public channels for Biotechnology Industry Research Assistance Council(BIRAC) include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Biotechnology Industry Research Assistance Council(BIRAC)?
The team at Biotechnology Industry Research Assistance Council(BIRAC) includes Douglas Rosenthal (Independent Researcher). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
